These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 25227201)
1. Genetic engineering of mesenchymal stem cells by non-viral gene delivery. Wang W; Xu X; Li Z; Lendlein A; Ma N Clin Hemorheol Microcirc; 2014; 58(1):19-48. PubMed ID: 25227201 [TBL] [Abstract][Full Text] [Related]
2. Genetic Engineering of Mesenchymal Stem Cells for Regenerative Medicine. Nowakowski A; Walczak P; Janowski M; Lukomska B Stem Cells Dev; 2015 Oct; 24(19):2219-42. PubMed ID: 26140302 [TBL] [Abstract][Full Text] [Related]
3. Non-viral oligonucleotide antimiR-138 delivery to mesenchymal stem cell sheets and the effect on osteogenesis. Yan J; Zhang C; Zhao Y; Cao C; Wu K; Zhao L; Zhang Y Biomaterials; 2014 Sep; 35(27):7734-49. PubMed ID: 24952983 [TBL] [Abstract][Full Text] [Related]
4. Gold nanorod delivery of LSD1 siRNA induces human mesenchymal stem cell differentiation. Zhao X; Huang Q; Jin Y Mater Sci Eng C Mater Biol Appl; 2015 Sep; 54():142-9. PubMed ID: 26046277 [TBL] [Abstract][Full Text] [Related]
5. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. Mauney JR; Volloch V; Kaplan DL Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765 [TBL] [Abstract][Full Text] [Related]
6. Osteogenically differentiated mesenchymal stem cells and ceramics for bone tissue engineering. Ohgushi H Expert Opin Biol Ther; 2014 Feb; 14(2):197-208. PubMed ID: 24308323 [TBL] [Abstract][Full Text] [Related]
7. Engineering of vascular grafts with genetically modified bone marrow mesenchymal stem cells on poly (propylene carbonate) graft. Zhang J; Qi H; Wang H; Hu P; Ou L; Guo S; Li J; Che Y; Yu Y; Kong D Artif Organs; 2006 Dec; 30(12):898-905. PubMed ID: 17181830 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cell fate following non-viral gene transfection strongly depends on the choice of delivery vector. Gonzalez-Fernandez T; Sathy BN; Hobbs C; Cunniffe GM; McCarthy HO; Dunne NJ; Nicolosi V; O'Brien FJ; Kelly DJ Acta Biomater; 2017 Jun; 55():226-238. PubMed ID: 28363788 [TBL] [Abstract][Full Text] [Related]
9. Non-viral gene delivery to mesenchymal stem cells: methods, strategies and application in bone tissue engineering and regeneration. Santos JL; Pandita D; Rodrigues J; Pêgo AP; Granja PL; Tomás H Curr Gene Ther; 2011 Feb; 11(1):46-57. PubMed ID: 21182464 [TBL] [Abstract][Full Text] [Related]
10. Human bone marrow native mesenchymal stem cells. Pontikoglou C; Delorme B; Charbord P Regen Med; 2008 Sep; 3(5):731-41. PubMed ID: 18729797 [TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells and their subpopulation, pluripotent muse cells, in basic research and regenerative medicine. Kuroda Y; Dezawa M Anat Rec (Hoboken); 2014 Jan; 297(1):98-110. PubMed ID: 24293378 [TBL] [Abstract][Full Text] [Related]
12. Comparative study of the biological characteristics of mesenchymal stem cells from bone marrow and peripheral blood of rats. Fu WL; Zhang JY; Fu X; Duan XN; Leung KK; Jia ZQ; Wang WP; Zhou CY; Yu JK Tissue Eng Part A; 2012 Sep; 18(17-18):1793-803. PubMed ID: 22721583 [TBL] [Abstract][Full Text] [Related]
13. Isolation and myogenic differentiation of mesenchymal stem cells for urologic tissue engineering. Wu R; Liu G; Bharadwaj S; Zhang Y Methods Mol Biol; 2013; 1001():65-80. PubMed ID: 23494421 [TBL] [Abstract][Full Text] [Related]
14. Minicircle microporation-based non-viral gene delivery improved the targeting of mesenchymal stem cells to an injury site. Mun JY; Shin KK; Kwon O; Lim YT; Oh DB Biomaterials; 2016 Sep; 101():310-20. PubMed ID: 27315214 [TBL] [Abstract][Full Text] [Related]
15. ScreenFect A: an efficient and low toxic liposome for gene delivery to mesenchymal stem cells. Li LM; Ruan GX; HuangFu MY; Chen ZL; Liu HN; Li LX; Hu YL; Han M; Davidson G; Levkin PA; Gao JQ Int J Pharm; 2015 Jul; 488(1-2):1-11. PubMed ID: 25895721 [TBL] [Abstract][Full Text] [Related]
16. Characterization and osteogenic potential of equine muscle tissue- and periosteal tissue-derived mesenchymal stem cells in comparison with bone marrow- and adipose tissue-derived mesenchymal stem cells. Radtke CL; Nino-Fong R; Esparza Gonzalez BP; Stryhn H; McDuffee LA Am J Vet Res; 2013 May; 74(5):790-800. PubMed ID: 23627394 [TBL] [Abstract][Full Text] [Related]
17. Non-viral gene therapy for bone tissue engineering. Wegman F; Oner FC; Dhert WJ; Alblas J Biotechnol Genet Eng Rev; 2013; 29():206-20. PubMed ID: 24568281 [TBL] [Abstract][Full Text] [Related]
18. Differentiation of GFP-Bcl-2-engineered mesenchymal stem cells towards a nucleus pulposus-like phenotype under hypoxia in vitro. Fang Z; Yang Q; Luo W; Li GH; Xiao J; Li F; Xiong W Biochem Biophys Res Commun; 2013 Mar; 432(3):444-50. PubMed ID: 23416353 [TBL] [Abstract][Full Text] [Related]